Search Results - "Gambini, Luca"

Refine Results
  1. 1

    Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl‑1 by Gambini, Luca, Udompholkul, Parima, Baggio, Carlo, Muralidharan, Aruljothi, Kenjić, Nikola, Assar, Zahra, Perry, J. Jefferson P, Pellecchia, Maurizio

    Published in Journal of medicinal chemistry (22-04-2021)
    “…Modulating disease-relevant protein–protein interactions (PPIs) using pharmacological tools is a critical step toward the design of novel therapeutic…”
    Get full text
    Journal Article
  2. 2

    Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate by Salem, Ahmed F, Wang, Si, Billet, Sandrine, Chen, Jie-Fu, Udompholkul, Parima, Gambini, Luca, Baggio, Carlo, Tseng, Hsian-Rong, Posadas, Edwin M, Bhowmick, Neil A, Pellecchia, Maurizio

    Published in Journal of medicinal chemistry (08-03-2018)
    “…EphA2 overexpression has been associated with metastasis in multiple cancer types, including melanomas and ovarian, prostate, lung, and breast cancers. We have…”
    Get full text
    Journal Article
  3. 3

    Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming by Barile, Elisa, Baggio, Carlo, Gambini, Luca, Shiryaev, Sergey A, Strongin, Alex Y, Pellecchia, Maurizio

    Published in Molecules (Basel, Switzerland) (22-05-2020)
    “…Processing of certain viral proteins and bacterial toxins by host serine proteases is a frequent and critical step in virulence. The coronavirus spike…”
    Get full text
    Journal Article
  4. 4

    Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates by Udompholkul, Parima, Baggio, Carlo, Gambini, Luca, Sun, Yu, Zhao, Ming, Hoffman, Robert M, Pellecchia, Maurizio

    Published in Molecules (Basel, Switzerland) (17-06-2021)
    “…We recently reported on a potent synthetic agent, 135H11, that selectively targets the receptor tyrosine kinase, EphA2. While 135H11 possesses a relatively…”
    Get full text
    Journal Article
  5. 5

    NMR Fingerprints of the Drug-like Natural-Product Space Identify Iotrochotazine A: A Chemical Probe to Study Parkinson's Disease by Grkovic, Tanja, Pouwer, Rebecca H., Vial, Marie-Laure, Gambini, Luca, Noël, Alba, Hooper, John N. A., Wood, Stephen A., Mellick, George D., Quinn, Ronald J.

    Published in Angewandte Chemie International Edition (10-06-2014)
    “…The NMR spectrum of a mixture of small molecules is a fingerprint of all of its components. Herein, we present an NMR fingerprint method that takes advantage…”
    Get full text
    Journal Article
  6. 6

    Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents by Salem, Ahmed F, Gambini, Luca, Udompholkul, Parima, Baggio, Carlo, Pellecchia, Maurizio

    Published in Pharmaceuticals (Basel, Switzerland) (10-05-2020)
    “…Recently, we reported on potent EphA2 targeting compounds and demonstrated that dimeric versions of such agents can exhibit remarkably increased agonistic…”
    Get full text
    Journal Article
  7. 7

    Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region by Gambini, Luca, Rizzi, Luca, Pedretti, Alessandro, Taglialatela-Scafati, Orazio, Carucci, Mario, Pancotti, Andrea, Galli, Corinna, Read, Martin, Giurisato, Emanuele, Romeo, Sergio, Russo, Ilaria

    Published in PloS one (13-11-2015)
    “…Malaria is an infectious disease caused by Plasmodium parasites. It results in an annual death-toll of ~ 600,000. Resistance to all medications currently in…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2 by Baggio, Carlo, Udompholkul, Parima, Gambini, Luca, Pellecchia, Maurizio

    Published in Journal of medicinal chemistry (24-11-2022)
    “…Overexpression of the receptor tyrosine kinase EphA2 is invariably associated with poor prognosis and development of aggressive metastatic cancers. Guided by…”
    Get full text
    Journal Article
  10. 10

    Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein by Udompholkul, Parima, Baggio, Carlo, Gambini, Luca, Alboreggia, Giulia, Pellecchia, Maurizio

    Published in Journal of medicinal chemistry (11-11-2021)
    “…We have recently reported on Lys-covalent agents that, based on aryl-sulfonyl fluorides, were designed to target binding site Lys 311 in the X-linked inhibitor…”
    Get full text
    Journal Article
  11. 11

    Covalent Inhibitors of Protein–Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues by Gambini, Luca, Baggio, Carlo, Udompholkul, Parima, Jossart, Jennifer, Salem, Ahmed F, Perry, J. Jefferson P, Pellecchia, Maurizio

    Published in Journal of medicinal chemistry (13-06-2019)
    “…We have recently reported a series of Lys-covalent agents targeting the BIR3 domain of the X-linked inhibitor of apoptosis protein (XIAP) using a…”
    Get full text
    Journal Article
  12. 12

    Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy by Baggio, Carlo, Udompholkul, Parima, Gambini, Luca, Salem, Ahmed F, Jossart, Jennifer, Perry, J. Jefferson P, Pellecchia, Maurizio

    Published in Journal of medicinal chemistry (24-10-2019)
    “…We have recently investigated the reactivity of aryl-fluorosulfates as warheads to form covalent adducts with Lys, Tyr, and His residues. However, the rate of…”
    Get full text
    Journal Article
  13. 13

    Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach by Baggio, Carlo, Gambini, Luca, Udompholkul, Parima, Salem, Ahmed F, Aronson, Alexander, Dona, Ada, Troadec, Estelle, Pichiorri, Flavia, Pellecchia, Maurizio

    Published in Journal of medicinal chemistry (26-07-2018)
    “…Recently we reported that rapid determination of enthalpy of binding can be achieved for a large number of congeneric agents or in combinatorial libraries…”
    Get full text
    Journal Article
  14. 14

    Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys‐Covalent Antagonists of Protein‐Protein Interactions by Gambini, Luca, Udompholkul, Parima, Salem, Ahmed F., Baggio, Carlo, Pellecchia, Maurizio

    Published in ChemMedChem (18-11-2020)
    “…Recently we reported on aryl‐fluorosulfates as possible stable and effective electrophiles for the design of lysine covalent, cell permeable antagonists of…”
    Get full text
    Journal Article
  15. 15

    Human resistin protects against endotoxic shock by blocking LPS–TLR4 interaction by Jang, Jessica C., Li, Jiang, Gambini, Luca, Batugedara, Hashini M., Sati, Sandeep, Lazar, Mitchell A., Fan, Li, Pellecchia, Maurizio, Nair, Meera G.

    “…Helminths trigger multiple immunomodulatory pathways that can protect from sepsis. Human resistin (hRetn) is an immune cell-derived protein that is highly…”
    Get full text
    Journal Article Web Resource
  16. 16

    Abstract 3911: Targeting the EphA2-ligand binding domain for the design of innovative cancer therapeutics by Udompholkul, Parima, Gambini, Luca, Salem, Ahmed F., Baggio, Carlo, Pellecchia, Maurizio

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract Eph receptors are the largest family of receptor tyrosine kinases, and are involved in regulating several cellular processes, including cell…”
    Get full text
    Journal Article
  17. 17

    Aryl-fluorosulfate-based Lysine Covalent pan-Inhibitors of Apoptosis Proteins (IAP) Antagonists with Cellular Efficacy by Baggio, Carlo, Udompholkul, Parima, Gambini, Luca, Salem, Ahmed F., Jossart, Jennifer, Perry, J. Jefferson P., Pellecchia, Maurizio

    Published in Journal of medicinal chemistry (08-10-2019)
    “…We have recently investigated the reactivity of aryl-fluorosulfates as warheads to form covalent adducts with Lys, Tyr, and His residues. However, the rate of…”
    Get full text
    Journal Article
  18. 18

    Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in Cell by Gambini, Luca, Salem, Ahmed F, Udompholkul, Parima, Tan, Xiao-Feng, Baggio, Carlo, Shah, Neh, Aronson, Alexander, Song, Jikui, Pellecchia, Maurizio

    Published in ACS chemical biology (21-09-2018)
    “…EphA2 overexpression is invariably associated with poor prognosis and development of aggressive metastatic cancers in pancreatic, prostate, lung, ovarian, and…”
    Get full text
    Journal Article
  19. 19
  20. 20

    N‐locking stabilization of covalent helical peptides: Application to Bfl‐1 antagonists by Baggio, Carlo, Udompholkul, Parima, Gambini, Luca, Jossart, Jennifer, Salem, Ahmed F., Håkansson, Maria, Perry, J. Jefferson P., Pellecchia, Maurizio

    Published in Chemical biology & drug design (01-04-2020)
    “…Recently, it was reported that tetrapeptides cyclized via lactam bond between the amino terminus and a glutamic residue in position 4 (termed here N‐lock) can…”
    Get full text
    Journal Article